Notify me when Joseph S. Freedman files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| EPRX | Eupraxia Pharmaceuticals Inc. | Common Shares | 10% | $29,215,375 | 5,533,215 | Joseph S. Freedman | 24 Sep 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|